Amarin | AMRN - Ingresos Por Ventas

Precio De Mercado
14.49
Cambio Diario
-0.51 -3.40%
Mensual
-7.29%
Anual
58.50%
Q1 Expectativa
14.05




Ventas Cambio Fecha
AbbVie USD 16.62B 840M 2025-12
Alnylam Pharmaceuticals USD 1.1B 150M 2025-12
Amarin USD 49.22M 451K 2025-12
AstraZeneca USD 15.5B 313M 2025-12
BioCryst Pharmaceuticals USD 406.56M 247.16M 2025-12
DBV Technologies USD 2.77M 1.31M 2025-09
Esperion Therapeutics USD 168.45M 81.14M 2025-12
GlaxoSmithKline GBP 8.62B 73M 2025-12
Halozyme Therapeutics USD 451.76M 97.76M 2025-12
Heron Therapeutics USD 40.59M 2.38M 2025-12
Ionis Pharmaceuticals USD 203M 46M 2025-12
Nektar Therapeutics USD 24.12M 635K 2024-09
Neurocrine Biosciences USD 805.5M 10.6M 2025-12
Novartis USD 13.86B 50M 2025-12